Recent findings reveal a troubling trend among individuals using weight-loss injections in the UK, with many resorting to unsafe practices in response to rising costs. Nearly half of the 1.6 million users admit to experimenting with hazardous dosing methods or purchasing medications from unregulated sources, raising serious health concerns.
Growing Concern Over Unsafe Practices
A new survey conducted by Lloyds Pharmacy Online Doctor highlights alarming statistics about weight-loss medication users. Approximately 32% of respondents reported attempting “microdosing,” while 28% admitted to sourcing drugs from unlicensed sellers. These methods are particularly concerning due to the potential health risks they pose.
One anonymous participant, referred to as Amy, shared her experience with Wegovy, a popular weight-loss injection. To stretch her supplies, Amy has resorted to using each needle twice, allowing her to extend the life of her medication. “I pay £150 for a 1 milligram pen, which if you’re on the full dose lasts four weeks. If I halve it, it lasts eight weeks,” she explained, indicating a growing desperation among users to manage costs.
Risks of Unregulated Sources
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued stern warnings regarding the dangers of obtaining weight-loss medications from unregulated suppliers. The manufacturer of Wegovy has labelled these practices as a “direct danger to health.” Dr Kieran Seyan, chief medical officer at Lloyds Pharmacy Online Doctor, expressed grave concerns about the rising trend of accessing prescription-only medications through unregulated sources like beauty therapists and salons.
“Medication sourced from unregulated suppliers increases the risk of incorrect dosing, expired products, and counterfeit medications,” he cautioned. This sentiment echoes through the community of healthcare professionals, who are alarmed by the potential for serious health complications stemming from these unsafe practices.
The Science Behind Weight-Loss Injections
Weight-loss injections, including Mounjaro and Wegovy, function as GLP-1 receptor agonists. They mimic a natural hormone responsible for regulating blood sugar levels, appetite, and digestion. While they are effective for many, the NHS limits access to patients with a BMI of 40 or more, although private providers may prescribe these injections to those with a BMI over 30.
Amy, who started on a low dose, reported significant weight loss but revealed her fears about discontinuing the medication. “I feel that I probably might be on it for good… I just think it’s something that I’ll be on for the foreseeable future,” she stated. Such dependency raises further questions about the long-term implications of these drugs.
The Dangers of Microdosing
Microdosing, a method where patients take smaller doses than prescribed, can lead to health complications. Dr Seyan noted that this approach is not scientifically validated and may result in inconsistent dosing, reducing the medication’s effectiveness. He highlighted the potential side effects, including nausea and abdominal pain, which can arise from erratic dosing.
Moreover, Amy’s practice of reusing needles to maximise her supply significantly heightens her risk of infection. Leyla Hanbeck, chief executive of the Independent Pharmacies Association, emphasised the importance of using sterile needles to prevent bacterial contamination. “A used needle is no longer sterile… there is also a risk of an inaccurate dose being administered,” she warned.
Regulatory Warnings and Patient Safety
The MHRA reiterated that Wegovy is a prescription-only medication and should only be procured from registered pharmacies following a healthcare professional’s consultation. Obtaining weight-loss drugs from unregulated sources can expose patients to falsified products that do not meet safety standards, increasing the risk of dangerous side effects.
Novo Nordisk, the manufacturer of Wegovy, has also condemned practices like microdosing. A spokesperson stated, “Patient safety is our top priority… we urge patients to only obtain appropriate medicine on prescription through legitimate sources.” They encouraged anyone suspecting they have received counterfeit medication to seek medical advice immediately.
Why it Matters
The surge in unsafe practices surrounding weight-loss injections illustrates a pressing public health concern. As individuals grapple with financial constraints and the desire for effective weight management solutions, the lure of shortcuts can lead to severe health repercussions. It is imperative for both healthcare providers and patients to prioritise safety and adhere to medically approved practices to ensure effective and secure weight-loss journeys.
